If your numbers are inside the lab's range, you're fine
Short answerNot the way you think
On this page
Not the way you think. The range printed beside each line is one line for every adult. The 2026 US guideline sets your LDL goal by your risk, from no number goal at low risk to under 55 mg/dL after a heart attack or stroke. Your lab doesn’t know your risk, so “in range” can still be far off for you.
What we’d do
Ignore the flags and the printed ranges. Ask your doctor which risk band you’re in, find your goal in the table below, and hold your LDL and non-HDL against that. If you’ve had a heart attack, stroke, stent or bypass, assume the printed range doesn’t apply to you at all, since your goal is far lower than most labs’ lines.
If you remember three things
- The range doesn’t know who you are. It’s the same for a 25 year old runner and a 65 year old with a stent.
- Your goal comes from your risk. Under 100, 70 or 55, or no number goal at low risk.
- ”High” can be fine too. Triglycerides of 160 after lunch get flagged against 150, but the line after a meal is 175.
Why people believe it
A lab report looks like a verdict. Each number sits next to a range, and anything outside it gets a bold H or L. No flag feels like a clean bill of health, and the report rarely says anything else.
That’s how ranges work for most blood tests, like sodium or potassium, where there’s one healthy band for nearly everyone. Cholesterol is different, because the right LDL depends on your chance of a heart attack or stroke, and that depends on your age, blood pressure, diabetes, smoking, kidneys and history. None of that is on the lab form.
Like the dose on a medicine bottle
The dose printed on a bottle of pills is written for a typical adult. Your doctor might tell you to take half, or twice as much, because they know things about you the label doesn’t. A lab’s cholesterol range is the label. Your goal is the dose your doctor would set.
The same LDL, three verdicts
Take an LDL of 95 mg/dL (2.5 mmol/L). Most reports would print it without a flag.
- At low risk, the guideline sets no number goal. Keep up the healthy habits.
- At borderline or intermediate risk, the goal is under 100, and 95 meets it.
- After a heart attack or stroke, most people’s goal is under 55. At 95 they’re 40 points over, a gap the guideline would close with medicine.
The goals by risk has the full table, including non-HDL.
When “high” isn’t
The flags can mislead the other way too. Many people now test without fasting, which the 2026 guideline accepts. A normal meal raises triglycerides by up to about 26 mg/dL for a few hours, so triglycerides of 160 after lunch may get flagged against a fasting line of 150, while the guideline’s line for a test after eating is 175. And in pregnancy, cholesterol rises on purpose, so none of the usual lines apply.
How common “in range but over goal” is
About 25% of US adults have an LDL of 130 or more, by the guideline’s count, and many more sit between 70 and 130, where their goal depends entirely on their risk. In 26 statin trials with about 170,000 people, each 39 mg/dL lower LDL cut major heart and blood vessel events by about a fifth, and the researchers found no level below which the benefit stopped, including in people who started under 77 mg/dL (2 mmol/L). The 2026 guideline adds that in one large trial of a PCSK9 drug, risk kept falling even in the 24% of people whose LDL went under 20.
Nobody is suggesting everyone needs an LDL of 20. What the trials show is that the best LDL for you depends on your risk, and the higher your risk, the further below the printed range it sits.

What to do with your report
- Find LDL and non-HDL. Non-HDL is your total minus your HDL.
- Find your risk band. Your doctor works it out from the PREVENT equations. If you don’t know it, compare with under 100, the most common goal.
- Put both into the panel check. Is my cholesterol bad? shows where you sit on every goal line, whatever your report printed.
4 sources
- Blumenthal RS, Morris PB, Gaudino M and others, 2026 ACC/AHA guideline on the management of dyslipidemia, JACC and Circulation, 2026doi.org
- Labcorp, 2026 ACC/AHA dyslipidemia guideline update (the goals table by risk)labcorp.com
- Cholesterol Treatment Trialists' Collaboration, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 2010pubmed.ncbi.nlm.nih.gov
- Langsted A, Freiberg JJ, Nordestgaard BG, Fasting and nonfasting lipid levels, Circulation, 2008pubmed.ncbi.nlm.nih.gov